The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II trial of second-line CAPTEM versus FOLFIRI in MGMT methylated, RAS mutated metastatic colorectal cancer (mCRC) patients.
 
Filippo Pietrantonio
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi; SERVIER
 
Riccardo Lobefaro
No Relationships to Disclose
 
Maria Antista
No Relationships to Disclose
 
Rosalba Miceli
No Relationships to Disclose
 
Alessandra Raimondi
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Lilly; Merck Serono
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Lorenza Rimassa
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Roche
Consulting or Advisory Role - Amgen; ArQule; Baxter; Bayer; Celgene; Eisai; Exelixis; Incyte; Ipsen; Italfarmaco; Lilly; Sanofi; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Serena Saggio
No Relationships to Disclose
 
Iolanda Capone
No Relationships to Disclose
 
Gabriella Farina
No Relationships to Disclose
 
Raffaella Longarini
No Relationships to Disclose
 
Stefania Mosconi
No Relationships to Disclose
 
Andrea Sartore-Bianchi
Honoraria - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Gianluca Tomasello
No Relationships to Disclose
 
Federica Perrone
No Relationships to Disclose
 
Ludovic Barault
No Relationships to Disclose
 
Massimo Milione
No Relationships to Disclose
 
Federica Di Nicolantonio
Research Funding - Trovagene (Inst)
Patents, Royalties, Other Intellectual Property - Submitted patent application of the use of circulating methylated markers for colorectal cancer (Inst)
 
Maria Di Bartolomeo
Honoraria - Amgen; Lilly; Merck Serono; Roche; SERVIER
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Dompè; Ignyta; Incyte; Novartis; Octimet; Pfizer; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Roche